retatrutide liver effects The power of three: Retatrutide's role in modern obesity and diabetes therapy Retatrutide vs Survodutide: 24% vs

Medically necessary in specific situations: If you have diabetes and take insulin or sulfonylureas (which can cause low blood sugar when combined with GLP-1s), blood sugar monitoring becomes important for safety

Starting at a lower dose (e.g., 2 mg instead of 4 mg) helps reduce gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation, which are more common with higher initial doses

Author contributions A.S.A.: study conception, design, data extraction, analysis, and manuscript writing

Adoption of GLP-1 therapies is being boosted by integrated care models for obesity and diabetes, expanded reimbursement policies, and inclusion of obesity medications in public health programs

This article examines the scientific rationale connecting GLP-1 signaling to Alzheimer's pathology, reviews current clinical trials, and clarifies what patients and clinicians should know about this evolving area of investigation